Sander Gary E相关文献与解析，生知库 | 链接生命科学的每一步

Kandavar, Ramprasad; Fernandez, Camilo; Sander, Gary E; Kim, Catherine; Velaga, Santhosh; Sukhanov, Sergiy; Delafontaine, Patrice; Egan, Peter; Roffidal, Louise E; Giles, Thomas D

心血管

高血压

代谢

发表日期：2015

文献求助收藏

Endothelial Progenitor Cells as a Biomarker for Transitional Phenotypes in Hypertension

内皮祖细胞作为高血压过渡表型的生物标志物

期刊:Journal of Clinical Hypertension

影响因子:2.5

doi:10.1111/jch.12567

Giles, Thomas D; Sander, Gary E

Vascular stiffness is a biomarker of global cardiovascular risk

血管僵硬是全球心血管风险的生物标志物。

期刊:Journal of Clinical Hypertension

影响因子:2.5

doi:10.1111/jch.12380

Sander, Gary E; Giles, Thomas D

发表日期：2014

文献求助收藏

Diastolic blood pressure and hypertension phenotypes: the US Food and Drug Administration has it right

舒张压和高血压表型：美国食品药品监督管理局的说法是正确的

期刊:Journal of Clinical Hypertension

影响因子:2.5

doi:10.1111/jch.12053

Giles, Thomas D; Sander, Gary E

Impaired vasodilation in the pathogenesis of hypertension: focus on nitric oxide, endothelial-derived hyperpolarizing factors, and prostaglandins

高血压发病机制中的血管舒张功能障碍：聚焦于一氧化氮、内皮源性超极化因子和前列腺素

期刊:Journal of Clinical Hypertension

影响因子:2.5

doi:10.1111/j.1751-7176.2012.00606.x

Giles, Thomas D; Sander, Gary E; Nossaman, Bobby D; Kadowitz, Philip J

The new International Classification of Diseases (ICD-10): the hypertension community needs a greater input

新的国际疾病分类（ICD-10）：高血压群体需要更多参与

期刊:Journal of Clinical Hypertension

影响因子:2.5

doi:10.1111/j.1751-7176.2011.00546.x

Giles, Thomas D; Sander, Gary E

Thiazide diuretics and β-blockers in the treatment of hypertension in diabetes mellitus

噻嗪类利尿剂和β受体阻滞剂治疗糖尿病合并高血压

期刊:Journal of Clinical Hypertension

影响因子:2.5

doi:10.1111/j.1751-7176.2011.00454.x

Sander, Gary E; Giles, Thomas D

Histologically measured cardiomyocyte hypertrophy correlates with body height as strongly as with body mass index

组织学测量的心肌细胞肥大与身高的相关性与体重指数的相关性一样强。

期刊:Cardiology Research and Practice

影响因子:1.8

doi:10.4061/2011/658958

Tracy, Richard E; Sander, Gary E

细胞生物学

发表日期：2011

文献求助收藏

The effect of nebivolol versus metoprolol succinate extended release on asymmetric dimethylarginine in hypertension.

奈必洛尔与琥珀酸美托洛尔缓释剂对高血压患者不对称二甲基精氨酸的影响

期刊:Journal of the American Society of Hypertension

影响因子:

doi:10.1016/j.jash.2010.11.003

Kandavar Ramprasad, Higashi Yusuke, Chen Wei, Blackstock Christopher, Vaughn Charlotte, Sukhanov Sergiy, Sander Gary E, Roffidal Louise E, Delafontaine Patrice, Giles Thomas D

Pathophysiologic, diagnostic, and therapeutic aspects of the metabolic syndrome

代谢综合征的病理生理学、诊断和治疗方面

期刊:Journal of Clinical Hypertension

影响因子:2.5

doi:10.1111/j.1524-6175.2005.04763.x

Giles, Thomas D; Sander, Gary E

Digital plethysmography and arginine metabolism in prehypertension: effect of nebivolol therapy

数字容积描记法和精氨酸代谢在高血压前期患者中的作用：奈必洛尔治疗的影响

Endothelial Progenitor Cells as a Biomarker for Transitional Phenotypes in Hypertension

内皮祖细胞作为高血压过渡表型的生物标志物

Vascular stiffness is a biomarker of global cardiovascular risk

血管僵硬是全球心血管风险的生物标志物。

Diastolic blood pressure and hypertension phenotypes: the US Food and Drug Administration has it right

舒张压和高血压表型：美国食品药品监督管理局的说法是正确的

Impaired vasodilation in the pathogenesis of hypertension: focus on nitric oxide, endothelial-derived hyperpolarizing factors, and prostaglandins

高血压发病机制中的血管舒张功能障碍：聚焦于一氧化氮、内皮源性超极化因子和前列腺素

The new International Classification of Diseases (ICD-10): the hypertension community needs a greater input

新的国际疾病分类（ICD-10）：高血压群体需要更多参与

Thiazide diuretics and β-blockers in the treatment of hypertension in diabetes mellitus

噻嗪类利尿剂和β受体阻滞剂治疗糖尿病合并高血压

Histologically measured cardiomyocyte hypertrophy correlates with body height as strongly as with body mass index

组织学测量的心肌细胞肥大与身高的相关性与体重指数的相关性一样强。

The effect of nebivolol versus metoprolol succinate extended release on asymmetric dimethylarginine in hypertension.

奈必洛尔与琥珀酸美托洛尔缓释剂对高血压患者不对称二甲基精氨酸的影响

Pathophysiologic, diagnostic, and therapeutic aspects of the metabolic syndrome

代谢综合征的病理生理学、诊断和治疗方面